Correspondence and papers re Milstein's commercial collaboration with Sera-Lab to produce antisera from his laboratory hybrid cell lines, monoclonal antisera, etc. and subsequent contract between the Medical Research Council and Sera-Lab.Includes Milstein's various comments and suggested amendments to the Sera-Lab products catalogue, and requests from other interested organisations concerning distribution of research reagents and related research matters.